Icon

Levoxyl - (0.025,0.05,0.1 mg; Tablet, Oral)

Levothyroxine Sodium King Pharma
0.025,0.05,0.1 mg; Tablet, Oral
Less Than $1000 mn
Less Than 5
Less Than 5
More Than 5
None
Less Than 5
Less Than 5
Used to treat hypothyroidism (low thyroid hormone)
Yes
**** ****** ***** * ** (******* ********) ********** **** *** *** ******* **** ********* ** ********* *** ****** *** **** ** ************ **** *** ************* ****** **** ******** ***** ******** ********* *** ******* ** ********** **** *** ********** ** ********* ************** *** ************* ****** **** ********. ******* *** ** *** ****** **** *** ***** ******* '* (**. *****, *****, *****, ******* * ***) ************ ***** ******** ******** ***** ****. ***** ********* ******** ************* **** ********* ***** ***** *** ***** *** *** ******* ************* ******* **** '* '*** ******. ***** & ** ****** ***** * **** ** *** ****** *******-*** **,**** *** *** ************ *********. ***** *** *** ***** ** ****.
Levoxyl Patent 1 Patent 2 Patent 3
***** ******* ******* *******
** ****** ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ** *** **** ******* ******** ******** ** *** **, ****
** ****** *** \ ** *** **** ******* **** ****** **** ********
  1. *****, **** : **** ****** ***** * ** ********** **** *** *** ******* **** ********* ** ********* *** ****** *** **** ** ************ **** *** ************* ****** **** ******** ***** ******** ********* *** ******* ** ********** **** *** ********** ** ********* ************** *** ************* ****** **** ********. ******* *** ** *** ********.
  2. *****, **** : ***** ******** **** ***** *** **** ** **** ******* ******* *** ****** *******(******* ****** **** *********** ** ****** & *********** ******).
  3. ****, **** : **** ***** * **** ******* ***** ** ** ******* ******** ***** ** ************ & ******** ******** ***** ** **** ******** **** ***** **** ***** ************ ** ******** ******** ***** ** **** ********.
  4. ****, **** : ** ****** ******** **** ***** *** **** ** **** ******* ******* *** ****** *******(******* ****** **** *********** ******). (*)*** ****: **** ***** * **** ******* **.
  5. ****, **** : ***** *** ***** ********.
  6. *** *, **** : ********** ********* **** ** ******
  7. *** **, **** : ********** ********* **** *****

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.